missing translation for 'onlineSavingsMsg'
Learn More
IBA Lifesciences MART-1 peptide ELAGIGILTV (HLA-A*0201) Product Code.: 15322126

IBA Lifesciences MART-1 peptide ELAGIGILTV (HLA-A*0201)
GREENER_CHOICE

Product Code. 15322126 Shop All IBA Lifesciences Products
1 mg, 1mg
Click to view available options
Quantity:
1 mg
Unit Size:
1mg
This item is not returnable. View return policy

Product Code. 15322126

Brand: IBA Lifesciences 67007901

Please to purchase this item. Need a web account? Register with us today!

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
View alternative products

This item is not returnable. View return policy

Single peptide synthesized as presented by the MHC class I allele

  • MART-1 peptide ELAGIGILTV (HLA-A*0201) is a single peptide for stimulation of T cells.
  • The peptide from melanoma antigen recognized by T cells 1 (MART-1) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.
  • The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.
  • Greener Choice Claims
    • Environmental benefits include:
      • Non-Toxic

    Specifications

    Content And Storage Recommended: -25°C to -15°C
    Quantity 1 mg
    Product Content Correction

    Your input is important to us. Please complete this form to provide feedback related to the content on this product.

    Product Title
    IBA Lifesciences MART-1 peptide ELAGIGILTV (HLA-A*0201) >

    By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

    Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.